» Articles » PMID: 29765269

Mohs Micrographic Surgery: Development, Technique, and Applications in Cutaneous Malignancies

Overview
Specialty General Surgery
Date 2018 May 17
PMID 29765269
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Mohs micrographic surgery (MMS) is a specialized technique for treating skin malignancies that offers the highest cure rate by allowing histological evaluation of the entire peripheral and deep margins. MMS also maximally preserves as much uninvolved, normal adjacent tissue as possible, allowing for the best cosmetic and functional outcomes. When used for appropriate indications, this technique is also more cost-effective than other treatment modalities. In this article, the authors will discuss the development of MMS, the steps involved in this procedure, and the indications for this technique. They will also review the use of MMS for basal cell carcinoma, squamous cell carcinoma, melanoma in situ, and some less common skin malignancies.

Citing Articles

Postoperative permanent section evaluation of Mohs micrographic surgery debulk specimens does not result in upstaging of cutaneous squamous cell carcinoma compared to stage at the completion of surgery: A retrospective case series.

Gilmore A, Castillo B, Golda N, Braudis K, Smith E JAAD Int. 2024; 15:100-104.

PMID: 38500871 PMC: 10945241. DOI: 10.1016/j.jdin.2024.01.005.


Squamous cell carcinoma of the eyelid.

Sato Y, Takahashi S, Toshiyasu T, Tsuji H, Hanai N, Homma A Jpn J Clin Oncol. 2023; 54(1):4-12.

PMID: 37747408 PMC: 10773209. DOI: 10.1093/jjco/hyad127.


More than Just Skin-Deep: A Review of Imaging's Role in Guiding CAR T-Cell Therapy for Advanced Melanoma.

Prendergast C, Capaccione K, Lopci E, Das J, Shoushtari A, Yeh R Diagnostics (Basel). 2023; 13(5).

PMID: 36900136 PMC: 10000712. DOI: 10.3390/diagnostics13050992.


Risk factors for complicated Mohs surgery in the South Sweden Mohs Cohort.

Natterdahl C, Kappelin J, Persson B, Lundqvist K, Ahnlide I, Saleh K J Eur Acad Dermatol Venereol. 2022; 36(7):1113-1117.

PMID: 35366359 PMC: 9324151. DOI: 10.1111/jdv.18124.


Site-Specific Vesicular Drug Delivery System for Skin Cancer: A Novel Approach for Targeting.

Pandey M, Choudhury H, Gorain B, Tiong S, Wong G, Chan K Gels. 2021; 7(4).

PMID: 34842689 PMC: 8628733. DOI: 10.3390/gels7040218.


References
1.
Tolkachjov S, Brodland D, Coldiron B, Fazio M, Hruza G, Roenigk R . Understanding Mohs Micrographic Surgery: A Review and Practical Guide for the Nondermatologist. Mayo Clin Proc. 2017; 92(8):1261-1271. DOI: 10.1016/j.mayocp.2017.04.009. View

2.
Holmkvist K, Roenigk R . Squamous cell carcinoma of the lip treated with Mohs micrographic surgery: outcome at 5 years. J Am Acad Dermatol. 1998; 38(6 Pt 1):960-6. DOI: 10.1016/s0190-9622(98)70160-4. View

3.
Gloster Jr H, Harris K, Roenigk R . A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996; 35(1):82-7. View

4.
Zitelli J, Brown C, Hanusa B . Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol. 1997; 37(2 Pt 1):236-45. DOI: 10.1016/s0190-9622(97)80131-4. View

5.
Leibovitch I, Huilgol S, Selva D, Hill D, Richards S, Paver R . Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion. J Am Acad Dermatol. 2005; 53(2):261-6. DOI: 10.1016/j.jaad.2005.03.048. View